Organotypic Collagen I Assay: A Malleable Platform to Assess Cell Behaviour in a 3-Dimensional Context
暂无分享,去创建一个
P. Timpson | E. McGhee | Zahra Erami | Max Nobis | J. Quinn | M. Edward | K. Anderson | M. Nobis
[1] A. Bohnert,et al. Growth and differentiation characteristics of transformed keratinocytes from mouse and human skin in vitro and in vivo. , 1983, The Journal of investigative dermatology.
[2] M. Edward,et al. Tumour regulation of fibroblast hyaluronan expression: a mechanism to facilitate tumour growth and invasion. , 2005, Carcinogenesis.
[3] M. Stone,et al. Development of a quantitative method to analyse tumour cell invasion in organotypic culture , 2005, The Journal of pathology.
[4] M. Edward,et al. Keratinocyte regulation of TGF‐β and connective tissue growth factor expression: A role in suppression of scar tissue formation , 2007, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[5] E. Sahai,et al. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells , 2007, Nature Cell Biology.
[6] Kenneth M. Yamada,et al. Modeling Tissue Morphogenesis and Cancer in 3D , 2007, Cell.
[7] Stephen J. Weiss,et al. Protease-dependent versus -independent cancer cell invasion programs: three-dimensional amoeboid movement revisited , 2009, The Journal of cell biology.
[8] Neil O Carragher,et al. Real-time study of E-cadherin and membrane dynamics in living animals: implications for disease modeling and drug development. , 2009, Cancer research.
[9] Jeffrey Wyckoff,et al. Invasion of human breast cancer cells in vivo requires both paracrine and autocrine loops involving the colony-stimulating factor-1 receptor. , 2009, Cancer research.
[10] J. Quinn,et al. 4‐Methylumbelliferone inhibits tumour cell growth and the activation of stromal hyaluronan synthesis by melanoma cell‐derived factors , 2010, The British journal of dermatology.
[11] N. Carragher,et al. Spatial regulation of RhoA activity during pancreatic cancer cell invasion driven by mutant p53. , 2011, Cancer research.